Preclinical detection of Alzheimer’s disease pathology using conceptual discrimination abilities
Given that impaired performance is observed earlier in the CMT than in standard neuropsychological tests, this test shows promise as an early diagnostic tool for AD and may offer significant utility in the context of clinical trials.
Authors
- Lara Huyghe (ORCID: https://orcid.org/0009-0009-3568-3474)
- Emma Delhaye (ORCID: https://orcid.org/0000-0001-9224-267X)
- Christine Bastin (ORCID: https://orcid.org/0000-0002-4556-9490)
- Renaud Lhommel (ORCID: https://orcid.org/0000-0003-0668-6122)
- Adrian Ivanoiu
- Thomas Gérard (ORCID: https://orcid.org/0000-0001-7997-3945)
- Gabriel Besson (ORCID: https://orcid.org/0000-0001-7752-8346)
- Bernard Hanseeuw (ORCID: https://orcid.org/0000-0002-3102-6778)
- Lisa Quenon (ORCID: https://orcid.org/0000-0001-9139-2422)
- Yasmine Salman (ORCID: https://orcid.org/0000-0002-8564-5136)
- Laurence Dricot (ORCID: https://orcid.org/0000-0002-8613-2420)
- Lise Colmant (ORCID: https://orcid.org/0009-0006-6511-0819)
- Vincent Malotaux (ORCID: https://orcid.org/0000-0003-0737-9220)
- Quentin Dessain (ORCID: https://orcid.org/0000-0002-7314-0413)
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- University of Liège (BE)
- Erasmus Hospital (BE)
- Massachusetts General Hospital (US)
- de Duve Institute (BE)
- UCLouvain Saint-Louis Brussels (BE)
- Walloon Excellence in Lifesciences and Biotechnology (BE)
- UCB Pharma (Belgium) (BE)
- UCLouvain (BE)
Publication Details
- Journal
- The Journal of Prevention of Alzheimer s Disease
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.tjpad.2025.100332
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fonds De La Recherche Scientifique - FNRS
- Walloon excellence in life sciences and biotechnology
- Smithsonian Astrophysical Observatory